CD4 levels and NSCLC metastasis: the benefits of maintaining moderate levels

Author:

Bai Ying,Liu Yafeng,Wu Jing,Miao Rui,Xu Zhi,Hu Chunxiao,Zhou Jiawei,Guo Jianqiang,Xie Jun,Shi Zilun,Ding Xuansheng,Xing Yingru,Hu Dong

Funder

Open Research Fund of Anhui Province Engineering Laboratory of Occupational Health and Safety

Graduate Innovation Foundation of AUST

the Collaborative Innovation Project of Colleges and Universities of Anhui Province

the National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Reference24 articles.

1. Anichini A, Perotti VE, Sgambelluri F, Mortarini R (2020) Immune escape mechanisms in non small cell lung cancer. Cancers (Basel). https://doi.org/10.3390/cancers12123605

2. Asselain B, Barriere JR, Clarot C, Vabre JP, Gentil LPB, Duval Y, Thomas P, Herman D, Grivaux M, Debieuvre D (2019) Metastatic NSCLC: clinical, molecular, and therapeutic factors associated with long-term survival. Respir Med Res 76:38–44. https://doi.org/10.1016/j.resmer.2019.07.001

3. Braumuller H, Wieder T, Brenner E, Assmann S, Hahn M, Alkhaled M, Schilbach K, Essmann F, Kneilling M, Griessinger C, Ranta F, Ullrich S, Mocikat R, Braungart K, Mehra T, Fehrenbacher B, Berdel J, Niessner H, Meier F, van den Broek M, Haring HU, Handgretinger R, Quintanilla-Martinez L, Fend F, Pesic M, Bauer J, Zender L, Schaller M, Schulze-Osthoff K, Rocken M (2013) T-helper-1-cell cytokines drive cancer into senescence. Nature 494:361–365. https://doi.org/10.1038/nature11824

4. Burt P, Peine M, Peine C, Borek Z, Serve S, Flossdorf M, Hegazy AN, Hofer T, Lohning M, Thurley K (2022) Dissecting the dynamic transcriptional landscape of early T helper cell differentiation into Th1, Th2, and Th1/2 hybrid cells. Front Immunol 13:928018. https://doi.org/10.3389/fimmu.2022.928018

5. Chae YK, Chang S, Ko T, Anker J, Agte S, Iams W, Choi WM, Lee K, Cruz M (2018) Epithelial–mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC). Sci Rep 8:2918. https://doi.org/10.1038/s41598-018-21061-1

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3